Group One Trading
CRDL

Group One Trading’s Cardiol Therapeutics CRDL Stock Holding History

Group One Trading’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.91K Sell
6,600
-211,900
-97% -$217K ﹤0.01% 6437
2025
Q4 		$208K Buy
218,500
+175,300
+406% +$184K ﹤0.01% 4337
2025
Q3 		$46.2K Buy
43,200
+29,100
+206% +$35.3K ﹤0.01% 6031
2025
Q2 		$19.2K Buy
14,100
+2,400
+21% +$2.79K ﹤0.01% 6288
2025
Q1 		$11.3K Buy
+11,700
New +$14.4K ﹤0.01% 6177
2024
Q4 		– Sell
-41,700
Closed -$82.6K – 7373
2024
Q3 		$82.6K Buy
41,700
+30,300
+266% +$62.9K ﹤0.01% 4324
2024
Q2 		$23K Sell
11,400
-14,200
-55% -$30.1K ﹤0.01% 5131
2024
Q1 		$46.3K Buy
+25,600
New +$34.5K ﹤0.01% 4784
2023
Q4 		– Sell
-5,800
Closed -$5.34K – 7498
2023
Q3 		$5.34K Buy
+5,800
New +$5.54K ﹤0.01% 6669
2022
Q2 		– Sell
-162,700
Closed -$251K – 7913
2022
Q1 		$251K Sell
162,700
-48,400
-23% -$79.8K ﹤0.01% 4559
2021
Q4 		$391K Buy
+211,100
New +$583K ﹤0.01% 4399

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's CRDL Position: Q4 2025 in Review

Group One Trading sold out of Cardiol Therapeutics (CRDL) in Q4 2025, closing a stake of 1,534 shares — an estimated $1.61K sold.

Group One Trading first reported a position in CRDL in Q4 2022 and held it in 12 quarters. The position peaked at $57.1K in Q2 2024. 41 funds tracked by Wall St. Rank hold CRDL as of Q4 2025.

  • Group One Trading reported no remaining Cardiol Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 1,534 Cardiol Therapeutics shares in Q4 2025, an estimated $1.61K.
  • Group One Trading first reported a position in Cardiol Therapeutics in Q4 2022 and held it in 12 quarters.
  • Group One Trading's Cardiol Therapeutics position peaked at $57.1K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.